Kevin Christopher is the founder and principal of Rockridge®, and is widely recognized for his work at the nexus of innovation + impact in venture ecosystems. Kevin’s daily work includes helping promising startups raise funds and secure intellectual property protection, providing due diligence to investors, acting as outside corporate counsel to impactful firms, and litigating complex patent and trademark suits. Kevin uniquely offers experiences as an entrepreneur, operator, director, investor, and litigator to best counsel firms at all stages of their existence.
Kevin Christopher is founder and principal of Rockridge Venture Law®, one of the only B Corp law firms in the U.S. and a Real Leaders Top 150 Impact Company. Kevin is also co-founder of Calliope Bio, a synthetic biology company launched from Yale, and QUANTiSCOPE, a microscopic AI company launched from Harvard/MIT.
Prior to founding Rockridge®, Kevin led biotech commercialization activities at UC Berkeley and Lawrence Livermore National Lab. Kevin is a Berkeley Form + Fund Fellow (startups), NIH RADx Faculty Member (technology), and Yale 2050 Fellow (sustainability). He’s been featured by B the Change, Forbes, the Los Angeles Times, Sustainable Brands Magazine, and many other media outlets for his work in impact + innovation. Kevin is a registered patent attorney and impact investor, and his practice areas include: corporate law and governance, data privacy, government contracts, intellectual property, startups, technology, and venture capital. Kevin is part of the World Economic Forum’s blockchain working group on Carbon Credits, and is a National Science Foundation (NSF) evaluator for the Center for Biocomposites and Bioplastics.
Kevin is currently documenting his path from overstressed entrepreneur-attorney to Ironman to raise awareness for self-care in the practice of law: @esquire_abs.